US 2024/0252500 A1 · Treatment of chronic pruritic dermatoses

Abstract

Treatment of chronic pruritic dermatoses by administration of seladelpar or a salt thereof, or by administration of mavodelpar or a salt thereof.

Claims18

Dependent claims

A method of treating a chronic pruritic dermatosis in a subject by administration to that subject of a therapeutically effective amount of a compound that is seladelpar or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application

18/423,232Filed 25 Jan 2024

Priority

29 Jan 2023

Published

1 Aug 2024

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/5375
Having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines: 1,4-Oxazines, e.g. morpholine
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid

Abstract

Treatment of chronic pruritic dermatoses by administration of seladelpar or a salt thereof, or by administration of mavodelpar or a salt thereof.

Treatment of chronic pruritic dermatoses

Life of this patent

Abstract

Claims18

Treatment of chronic pruritic dermatoses

Life of this patent

Abstract

Claims18